Get 40% Off
🤑 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Tokyo shares retreat as firmer yen weighs on exporters

Published 11/19/2019, 10:13 AM
Updated 11/19/2019, 10:16 AM
Tokyo shares retreat as firmer yen weighs on exporters
USD/JPY
-
JP225
-
TOPX
-
4188
-
6758
-
3436
-
6954
-
9984
-
4508
-
6146
-
7203
-

TOKYO, Nov 19 (Reuters) - Japan's stock benchmark Nikkei
edged down on Tuesday as investors await clarity on the progress
of U.S-China trade negotiations, with exporters pressured by a
firmer yen against the dollar.
The Nikkei share average .N225 dropped 0.2% to 23,361.35
in late-morning trade, and the broader Topix .TOPX fell 0.1%
at 1,698.44.
Wall Street's main indexes were mostly flat, looking for
direction on trade, though they ended the day inching up to
record high closing levels. .N/C
Overnight, CNBC reported the mood in Beijing was pessimistic
about the prospects of sealing a phase-one deal with Washington.
On the other hand, a new extension allowing U.S. companies
to continue doing business with Chinese telecoms giant Huawei
Technologies Co Ltd HWT.UL suggested something of an olive
branch. The Japanese yen firmed as much as 0.2% to 108.47 JPY=
versus the dollar early on Tuesday, weighing on exporters as a
strong local currency hurts corporate profits when they are
repatriated.
Export-oriented Fanuc Corp 6954.T shed 1.0%, while Toyota
Motor Corp 7203.T fell 0.7% and Sony Corp 6758.T shed 1.3%.
Semiconductor-related shares retreated as some profit-taking
selling kicked in, with SUMCO Corp 3436.T shedding 2.3% and
Disco Corp 6146.T falling 0.5%.
The Nikkei's heavyweight SoftBank Group Corp 9984.T fell
1.4% after Reuters reported that the New York State Attorney
General is investigating WeWork, citing sources. Group is the majority owner of the office-sharing
startup.
Elsewhere, Mitsubishi Chemical Holdings Corp 4188.T dived
3.5% after Japan's largest chemical maker said it will pay 491.8
billion yen ($4.5 billion) to make Mitsubishi Tanabe Pharma Corp
a fully-owned subsidiary. Mitsubishi Tanabe Pharma
4508.T shares were untraded amid heavy buy orders.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.